1. Home
  2. AIXI vs DCOY Comparison

AIXI vs DCOY Comparison

Compare AIXI & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIXI

XIAO-I Corporation

HOLD

Current Price

$0.85

Market Cap

2.7M

Sector

Technology

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$5.95

Market Cap

3.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIXI
DCOY
Founded
2001
N/A
Country
China
United States
Employees
N/A
11
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
AIXI
DCOY
Price
$0.85
$5.95
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
94.8M
13.9K
Earning Date
05-14-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.84
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.53
52 Week High
$4.02
$9.09

Technical Indicators

Market Signals
Indicator
AIXI
DCOY
Relative Strength Index (RSI) 53.94 50.71
Support Level $0.31 $5.40
Resistance Level $1.78 $9.09
Average True Range (ATR) 0.37 0.68
MACD 0.02 -0.22
Stochastic Oscillator 28.76 19.05

Price Performance

Historical Comparison
AIXI
DCOY

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: